Atlas Trials

The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Clinical trial NCT04185649 · UNKNOWN

Trial details

NCT number
NCT04185649
Sponsor
Bio-Thera Solutions
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
HER2-positive Advanced Breast Cancer
Start date
2018-07-01
Primary completion
2020-07-31
Enrollment
410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.